GI
ANGO icon

GAMMA Investing’s AngioDynamics ANGO Stock Holding History

GAMMA Investing’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$44.6K Buy
2,902
+718
+33% +$10.7K ﹤0.01% 2440
2026
Q2 		$28.4K Buy
2,184
+325
+17% +$3.7K ﹤0.01% 2653
2026
Q1 		$21.1K Buy
1,859
+165
+10% +$1.79K ﹤0.01% 2683
2025
Q4 		$21.8K Buy
1,694
+329
+24% +$4.06K ﹤0.01% 2562
2025
Q3 		$15.2K Sell
1,365
-335
-20% -$3.23K ﹤0.01% 2663
2025
Q2 		$16.9K Buy
1,700
+220
+15% +$2.15K ﹤0.01% 2545
2025
Q1 		$13.9K Buy
1,480
+474
+47% +$4.98K ﹤0.01% 2585
2024
Q4 		$9.21K Buy
1,006
+408
+68% +$3K ﹤0.01% 2658
2024
Q3 		$4.65K Buy
598
+216
+57% +$1.56K ﹤0.01% 2772
2024
Q2 		$2.31K Buy
382
+258
+208% +$1.59K ﹤0.01% 2841
2024
Q1 		$728 Sell
124
-656
-84% -$3.9K ﹤0.01% 3017
2023
Q4 		$4.6K Buy
+780
New +$5.41K ﹤0.01% 2277

Other funds holding ANGO

MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's ANGO Position: Q3 2026 in Review

GAMMA Investing increased its AngioDynamics (ANGO) stake by 33% in Q3 2026, buying an estimated $10.7K and bringing the position to 2,902 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2440.

GAMMA Investing first reported a position in ANGO in Q4 2023 and has held it in 12 quarters since. 5 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • GAMMA Investing held 2,902 shares of AngioDynamics worth $44.6K as of Q3 2026.
  • GAMMA Investing bought 718 AngioDynamics shares in Q3 2026, an estimated $10.7K.
  • AngioDynamics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2440 holding.
  • GAMMA Investing first reported a position in AngioDynamics in Q4 2023 and has held it in 12 quarters since.
  • 5 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.